Border to Coast Pensions Partnership Ltd Has $45.68 Million Stock Position in Danaher Co. (NYSE:DHR)

Border to Coast Pensions Partnership Ltd boosted its holdings in Danaher Co. (NYSE:DHR - Free Report) by 13.1% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 199,150 shares of the conglomerate's stock after acquiring an additional 23,123 shares during the period. Border to Coast Pensions Partnership Ltd's holdings in Danaher were worth $45,684,000 at the end of the most recent quarter.

Other institutional investors also recently made changes to their positions in the company. Decker Retirement Planning Inc. acquired a new position in shares of Danaher during the fourth quarter worth approximately $31,000. Teachers Insurance & Annuity Association of America bought a new position in shares of Danaher in the third quarter worth $39,000. MidAtlantic Capital Management Inc. acquired a new position in shares of Danaher during the third quarter valued at $40,000. FSA Wealth Management LLC bought a new stake in shares of Danaher during the third quarter valued at about $50,000. Finally, Darwin Wealth Management LLC acquired a new stake in Danaher in the third quarter worth about $55,000. 79.05% of the stock is owned by institutional investors.

Danaher Stock Performance

DHR stock traded down $3.49 during trading on Friday, reaching $238.41. 3,044,734 shares of the stock were exchanged, compared to its average volume of 2,640,177. The stock has a 50 day simple moving average of $234.85 and a 200-day simple moving average of $253.32. The company has a current ratio of 1.37, a quick ratio of 1.01 and a debt-to-equity ratio of 0.32. The company has a market capitalization of $172.20 billion, a P/E ratio of 45.50, a price-to-earnings-growth ratio of 4.23 and a beta of 0.83. Danaher Co. has a twelve month low of $222.53 and a twelve month high of $281.70.

Danaher (NYSE:DHR - Get Free Report) last issued its earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 EPS for the quarter, beating analysts' consensus estimates of $1.57 by $0.14. The business had revenue of $5.80 billion during the quarter, compared to analyst estimates of $5.59 billion. Danaher had a return on equity of 10.62% and a net margin of 16.39%. Danaher's revenue was up 3.1% on a year-over-year basis. During the same period in the prior year, the company posted $2.02 earnings per share. As a group, sell-side analysts anticipate that Danaher Co. will post 7.49 earnings per share for the current year.

Danaher Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Friday, December 27th will be paid a $0.27 dividend. The ex-dividend date is Friday, December 27th. This represents a $1.08 dividend on an annualized basis and a yield of 0.45%. Danaher's payout ratio is currently 20.61%.

Analyst Upgrades and Downgrades

Several analysts have recently weighed in on the company. Barclays cut their price objective on Danaher from $285.00 to $275.00 and set an "equal weight" rating for the company in a report on Wednesday, October 23rd. KeyCorp raised their price objective on shares of Danaher from $290.00 to $310.00 and gave the company an "overweight" rating in a research report on Wednesday, October 23rd. Raymond James lowered their price objective on shares of Danaher from $310.00 to $300.00 and set an "outperform" rating on the stock in a research note on Wednesday, October 23rd. Robert W. Baird cut their target price on shares of Danaher from $278.00 to $277.00 and set an "outperform" rating for the company in a research note on Wednesday, October 23rd. Finally, TD Cowen lifted their price target on shares of Danaher from $310.00 to $315.00 and gave the stock a "buy" rating in a research report on Wednesday, October 23rd. Six analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of $286.80.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.